Reply to: "Phase 2a randomized clinical trial of dupilumab (anti-IL-4R&#945;) for alopecia areata patients".

Reply to: "Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients".

Renert-Yuval, Yael; Guttman-Yassky, Emma.

Afiliação

Renert-Yuval Y; Department of Dermatology, and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Guttman-Yassky E; Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA.

Allergy ; 77(7): 2269-2270, 2022 07.

Article em En | MEDLINE | ID: mdl-35770817

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article